ChromoGenics AB (OSTO:CHRO) Total Stockholders Equity : kr29.15 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is ChromoGenics AB Total Stockholders Equity?

ChromoGenics AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr29.15 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. ChromoGenics AB's Book Value per Share for the quarter that ended in Mar. 2024 was kr7.07. The ratio of a company's debt over equity can be used to measure how leveraged this company is. ChromoGenics AB's Debt-to-Equity for the quarter that ended in Mar. 2024 was 2.32.

ChromoGenics AB Total Stockholders Equity Historical Data

The historical data trend for ChromoGenics AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChromoGenics AB Total Stockholders Equity Chart

ChromoGenics AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

-39.90

42.61

120.93

57.70

70.49

ChromoGenics AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															70.49	63.02	51.11	59.34	29.15

ChromoGenics AB (OSTO:CHRO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

ChromoGenics AB's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(29.146	-	0)	/	4.12497
	=	7.07

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

ChromoGenics AB's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	67.724)	/	29.146
	=	2.32

ChromoGenics AB Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of ChromoGenics AB's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ChromoGenics AB (OSTO:CHRO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Construction » ChromoGenics AB (OSTO:CHRO) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

384:Germany

Address

Ullforsgatan 15, Uppsala, SWE, 752 28

Website

http://www.chromogenics.com

ChromoGenics AB develops and produces dynamic glass with controllable optical properties in Sweden and internationally. The company offers ConverLight, an electrochromic glass, which provides UV protection for use in single glass pane and insulating glass unit solutions. This glass is suitable for new construction, reconstruction, and renovation and offers ultraviolet protection that reduces the risk of fading interiors.